ProCE Banner Activity

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Managing Immune Checkpoint Inhibitor Related Toxicities: An Interactive Decision Support Tool

Tool

Use this mobile-friendly interactive algorithm tool to receive National Comprehensive Cancer Network® (NCCN®) guidance on optimal management of immune-related adverse events associated with immune checkpoint inhibitor therapy, adapted from the NCCN Guidelines for Management of Immunotherapy-Related Toxicities v3.2021.

Share

Provided by

ProCE Banner

Supporters

Bristol Myers Squibb

Merck Sharp & Dohme Corp.